Xtant Medical Holdings, Inc.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US98420P3082
USD
0.56
-0.02 (-3.3%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Axogen, Inc.
Xtant Medical Holdings, Inc.
Bioventus, Inc.
TELA Bio, Inc.
908 Devices, Inc.
Harvard Bioscience, Inc.
Sight Sciences, Inc.
Butterfly Network, Inc.
Semler Scientific, Inc.
Celcuity, Inc.
Jin Medical International Ltd.

Why is Xtant Medical Holdings, Inc. ?

Icon
Unrated Stock - No Analysis Available
stock-recommendationReal-Time Research Report

Verdict Report

How much should you buy?

  1. Overall Portfolio exposure to Xtant Medical Holdings, Inc. should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Icon
No Data Found
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
18.78%
EBIT Growth (5y)
46.93%
EBIT to Interest (avg)
-2.59
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0.65
Sales to Capital Employed (avg)
1.39
Tax Ratio
0.79%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
0.38%
ROE (avg)
0
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
50
Industry P/E
Price to Book Value
1.75
EV to EBIT
16.87
EV to EBITDA
9.82
EV to Capital Employed
1.55
EV to Sales
0.80
PEG Ratio
0.46
Dividend Yield
NA
ROCE (Latest)
9.16%
ROE (Latest)
3.48%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

18What is working for the Company
PRE-TAX PROFIT(Q)

At USD 1.56 MM has Grown at 246.67%

NET PROFIT(Q)

At USD 1.31 MM has Grown at 214.21%

OPERATING CASH FLOW(Y)

Highest at USD 7.77 MM

RAW MATERIAL COST(Y)

Fallen by -13.53% (YoY

0What is not working for the Company
Icon
NO KEY NEGATIVE TRIGGERS

Here's what is working for Xtant Medical Holdings, Inc.

Pre-Tax Profit
At USD 1.56 MM has Grown at 246.67%
over average net sales of the previous four periods of USD -1.07 MM
MOJO Watch
Near term Pre-Tax Profit trend is very positive

Pre-Tax Profit (USD MM)

Net Profit
At USD 1.31 MM has Grown at 214.21%
over average net sales of the previous four periods of USD -1.15 MM
MOJO Watch
Near term Net Profit trend is very positive

Net Profit (USD MM)

Operating Cash Flow
Highest at USD 7.77 MM
in the last three years
MOJO Watch
The company has generated higher cash revenues from business operations

Operating Cash Flows (USD MM)

Raw Material Cost
Fallen by -13.53% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales